Jim Cramer labels Vertex Pharmaceuticals a buy, citing its impactful mission. Analysts project a 22.33% upside for Vertex stock, despite current bearish momentum. Memorial Day Special: Access your ...

Vertex, Inc. is rated a Buy due to steady growth, margin expansion, recurring revenue, and high retention. Learn more about ...

Despite commanding over 90% of its revenue from its cystic fibrosis drug franchise, Vertex has been unable to fend off investor skepticism. In 2024, the company made waves with CASGEVY, the first gene ...

Want an edge in trading? Follow the Big Money. What’s Big Money? Said simply, it’s when a stock rises due to institutional demand. Top stocks tend to attract savvy investors. You see, fund managers ...